603301.SH
振德医疗
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 82.29
+0.57%Year over year
Reported trailing growth
- Revenue
- +1.1%
- EBITDA
- —
- EBIT
- -28.9%
- EPS
- -27.1%
- Free cash flow
- +135.1%
- Operating cash flow
- +40.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -11.0%
- EBITDA
- -14.4%
- EBIT
- -26.1%
- Net income
- -27.3%
- EPS
- -29.9%
- Free cash flow
- +96.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026